Core Scientific’s Top Investor to Vote Against CoreWeave’s ‘Inadequate’ $9B Takeover

In brief Two Seas Capital, Core Scientific’s largest active shareholder with a 6.3% stake, is opposing a $9 billion all-stock sale to CoreWeave. The hedge fund says the uncollared structure leaves investors exposed to CoreWeave’s volatile stock with no value protections. A shareholder vote later this year will coincide with CoreWeave’s IPO lockup expiry, potentially...